Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Internal Receptors

Internal Receptors

Many cellular signals are hydrophilic and therefore cannot pass through the plasma membrane. However, small or hydrophobic signaling molecules can cross the hydrophobic core of the plasma membrane and bind to internal, or intracellular, receptors that reside within the cell. Many mammalian steroid hormones use this mechanism of cell signaling, as does nitric oxide (NO) gas.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First Measurement of Time-Dependent CP Violation in the Flavor-Changing Neutral-Current Decay B^{0}→K_{S}^{0}μ^{+}μ^{-}.

Physical review letters·2026

Same author

Measurement of the Top-Quark Production Cross Section and Charge Asymmetry at LHCb.

Physical review letters·2026

Same author

Searches for B^{0}→K^{+}π^{-}τ^{+}τ^{-} and B_{s}^{0}→K^{+}K^{-}τ^{+}τ^{-} Decays.

Physical review letters·2026

Same author

First Evidence of the B_{s}^{0}→K^{-}π^{+}γ Decay.

Physical review letters·2026

Same author

Precision Measurement of CP Violation and Branching Fractions in B^{±}→K_{S}^{0}h^{±} (h=π, K) Decays and Search for the Rare Decay B_{c}^{±}→K_{S}^{0}K^{±}.

Physical review letters·2026

Same author

First Observation of the B[over ¯]_{s}^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay and Evidence for the B[over ¯]^{0}→Λ_{c}^{+}Λ[over ¯]_{c}^{-} Decay.

Physical review letters·2026

Same journal

Fresh vs. frozen donor oocytes: which strategy best serves patients in contemporary assisted reproductive technology?

Fertility and sterility·2026

Same journal

From fetal life to adulthood: cardiometabolic health of offspring conceived by assisted reproductive technologies, a systematic review.

Fertility and sterility·2026

Same journal

Uterus-Sparing Laparoscopic Reversal of Complete Non-Puerperal uterine Inversion: A rare Case and Challenging Procedure!

Fertility and sterility·2026

Same journal

Minimally Invasive, Fertility-Sparing Surgical Management of Multiple Bilateral Ovarian Dermoid Cysts.

Fertility and sterility·2026

Same journal

Preconception dietary patterns in association with live birth and pregnancy loss: a couples-based approach.

Fertility and sterility·2026

Same journal

Corrigendum to "Clinical management of mosaic results from preimplantation genetic testing for aneuploidy of blastocysts: a committee opinion" [Fertil Steril 2023;120:973-82].

Fertility and sterility·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 26, 2026

Obtaining Human Microglia from Adult Human Brain Tissue

Obtaining Human Microglia from Adult Human Brain Tissue

Published on: August 30, 2020

Progestins and androgens

¹King's Healthcare Trust, King's College Hospital, London, United Kingdom.

Fertility and Sterility

|December 1, 1994

Summary

This summary is machine-generated.

Adding progestin or androgen to estrogen replacement therapy (ERT) alters its effects on arterial disease risk factors. The impact on lipids and lipoproteins is complex, with both beneficial and adverse modifications observed, necessitating further research.

More Related Videos

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Related Experiment Videos

Last Updated: Jan 26, 2026

Obtaining Human Microglia from Adult Human Brain Tissue

Obtaining Human Microglia from Adult Human Brain Tissue

Published on: August 30, 2020

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Prostate Organoid Cultures as Tools to Translate Genotypes and Mutational Profiles to Pharmacological Responses

Published on: October 24, 2019

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

Area of Science:

Cardiovascular Health
Endocrinology
Pharmacology

Background:

Estrogen replacement therapy (ERT) has known effects on arterial disease risk.
The influence of combined hormone therapies on cardiovascular markers requires clarification.

Purpose of the Study:

To evaluate how progestin or androgen addition to ERT modifies estrogen's effects on arterial disease risk.
To synthesize current literature on the cardiovascular implications of combined hormone therapies.

Main Methods:

Literature review of population studies, clinical trials, and laboratory investigations.
Focus on postmenopausal women receiving exogenous progestin or androgen with estrogen.
Analysis of outcomes including lipids, lipoproteins, carbohydrate metabolism, and coagulation.

Main Results:

Progestin and androgen addition modify estrogen-induced lipid and lipoprotein changes.
Progestins show potentially adverse effects (lowering HDL2-C) and beneficial effects (lowering triglycerides).
Data on androgens suggest they may counteract estrogen's positive effects on HDL cholesterol, with overall clinical effects remaining unpredictable.

Conclusions:

The addition of progestins or androgens to ERT significantly alters cardiovascular risk profiles.
Current data are insufficient to predict the precise clinical outcomes of combined hormone therapies.
Further research is crucial to elucidate the complex interactions and long-term effects on arterial health.